Loading company…
The IT Lab develops diagnostic products, including saliva-based kits to assess cancer risk.
Founded in 2022, The IT Lab develops medical kits that use microRNA information from saliva samples to detect cancer risk. It also develops clinical diagnostic materials and medical device systems for genomic medicine. The company is based in Morioka, Japan, and led by CEO Yoshihiro Taguchi. In November 2024, it received venture funding from Future Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in